Mesenchymal Cell News 8.31 August 9, 2016 | |
| |
TOP STORYScientists investigated whether mesenchymal stem cells enhance the phagocytic clearance of α-synuclein via M2 microglia polarization, and thereby exert neuroprotective effects in α-synuclein-enriched experimental models and patients with multiple system atrophy. [Acta Neuropathol] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROThe authors investigated the role of autophagy in cadmium-induced skeleton damage and its potential mechanism. They exposed mesenchymal stem cells to different concentrations of cadmium chloride for 24 hours. [Toxicol Sci] Abstract Researchers investigated the molecular role of insulin-like growth factor-binding protein 5 (IGFBP5) in regulating this osteogenic differentiation potential. [Cell Prolif] Abstract Investigators report for the first time, such a serum-free, xeno-free, completely chemically defined and no-plate-coating-based culture system for the isolation and expansion of umbilical cord mesenchymal stromal cells, whose biological characteristics were evaluated and compared with serum-containing medium methods. [Cell Prolif] Abstract Through analyzing levels of mRNA and protein markers associated with beige adipocyte, scientists found concomitant beige adipocyte differentiation upon induction of mesenchymal stem cells into brown adipocytes in a defined medium containing triiodothyronine, insulin, dexamethasone, and indomethacin. [Biochem Biophys Res Commun] Abstract Researchers aimed to identify the potential effect of chondrogenic pre-differentiation on adipose-derived mesenchymal stem cells in intervertebral disc-like microenvironment, characterized by limited nutrition, acidic, and high osmosis in vitro. [Exp Biol Med] Abstract IN VIVOInvestigators hypothesized that treatment of human embryonic stem cell (ESC)-derived chondroprogenitors with bone morphogenetic protein 2 (BMP-2) followed by wingless-type MMTV integration site family, member 5A (Wnt5a) may control the maturational progression of these cells into a hyaline-like chondrocyte phenotype. [Stem Cells Transl Med] Abstract | Full Article Three different mesenchymal stem cells (MSCs) delivery routes: IP, IV, and AI were compared on DSS-induced colitic mice model. The overall therapeutic factors, MSCs migration and targeting as well as local immunomodulatory cytokines and FoxP3+ cells infiltration were analyzed. [Sci Rep] Full Article | |
| |
REVIEWSProspects and Progress in Cell Therapy for Acute Respiratory Distress Syndrome The authors discuss the use of mesenchymal stromal (stem) cells in pre-clinical experimental models of acute respiratory distress syndrome and in ongoing clinical trials. [Expert Opin Biol Ther] Abstract Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSFibroStatin Announces Breakthrough in the Fight Against Drug-Resistant Cancer and Fibrosis FibroStatin announced the development of a breakthrough treatment to inhibit the epithelial-mesenchymal transition, a fundamental underlying pathology active in drug-resistant invasive cancer and organ fibrosis. [FibroStatin (PR Newswire Association LLC.)] Press Release Mesoblast Limited announced that a single intravenous infusion of its proprietary allogeneic mesenchymal precursor cell (MPC) product candidate, MPC-300-IV, was well tolerated and demonstrated a dose-related improvement in clinical symptoms, physical function, and disease activity relative to placebo through the 12 week primary endpoint in its Phase II trial in biologic refractory rheumatoid arthritis. [Mesoblast Limited (GlobeNewswire)] Press Release | |
| |
POLICY NEWSRussian Scientists Bracing for Massive Job Losses Russia’s scientific community is reeling from news that the government plans to fire about 10,000 researchers over the next three years. [ScienceInsider] Editorial The FDA Is Prohibited from Going Germline A potentially renewable provision of the Consolidated Appropriation Act of 2016 forestalling the prospect of human germline modification was signed into law on December 18th, 2015. The provision has since been incorporated again into the House and Senate appropriation bills for the fiscal year. [ScienceInsider] Editorial US Agency Lifts Ban on Funding Human–Animal Hybrids Researchers in the United States will soon be able to resume creating chimaera-based projects. [Nature News] Editorial Beyond CRISPR: A Guide to the Many Other Ways to Edit a Genome The zeal with which researchers jumped on a possible new gene-editing system called NgAgo earlier this year reveals an undercurrent of frustration with CRISPR–Cas9 — and a drive to find alternatives. [Nature News] Editorial
| |
EVENTSNEW 21st Annual Congress of Asia Pacific Blood and Marrow Transplantation Group 2016 (APBMT 2016) Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESAssistant or Associate Member – Stem Cell/Gene Therapy (Fred Hutchinson Cancer Research Center) Postdoctoral Position – Organogenesis and Mesenchymal Stem Cells (University of Southern California) Postdoctoral Positions – GLUT4 Trafficking in Adipose and Muscle Cells (ShanghaiTech University) Postdoctoral Position – Tumor Microenvironment in Sarcoma Progression (Universita’ di Bologna) Cell Biologist – Mesenchymal Stem Cells (Biostage) Postdoctoral Position – Bone and Stem Cell Research (University of Connecticut Health) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Mesenchymal Cell News Volume 8.31 | Aug 9 2016